Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hutterer

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
BJU International|November 6, 2007
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancerJochen Walz, Andrea Gallina, Paul Perrotte, et al.
International Journal of Cancer|April 25, 2007
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European menAndrea Gallina, Pierre I Karakiewicz, Georg C Hutterer, et al.
BJU International|September 14, 2007
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomyAndrea Gallina, Alberto Briganti, Felix K-H Chun, et al.
European Urology|March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millenniumFelix K-H Chun, Alberto Briganti, Andrea Gallina, et al.
BJU International|October 3, 2007
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogramGeorg C Hutterer, Jean-Jacques Patard, Claudio Jeldres, et al.
BJU International|September 14, 2007
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survivalPatrick J Bastian, Georg C Hutterer, Shahrokh F Shariat, et al.
International Journal of Molecular Sciences|October 17, 2018
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor PatientsAngelika Terbuch, Jan B Adiprasito, Verena Stiegelbauer, et al.
Frontiers in Oncology|December 16, 2021
Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)Steffen Lebentrau, Gamal Anton Wakileh, Martin Schostak, et al.
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
Cancers|December 23, 2023
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder CancerLukas Scheipner, Hanna Zurl, Julia V Altziebler, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
BJU International|November 6, 2007
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancerJochen Walz, Andrea Gallina, Paul Perrotte, et al.
International Journal of Cancer|April 25, 2007
Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European menAndrea Gallina, Pierre I Karakiewicz, Georg C Hutterer, et al.
BJU International|September 14, 2007
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomyAndrea Gallina, Alberto Briganti, Felix K-H Chun, et al.
European Urology|March 27, 2007
Prostate-specific antigen improves the ability of clinical stage and biopsy Gleason sum to predict the pathologic stage at radical prostatectomy in the new millenniumFelix K-H Chun, Alberto Briganti, Andrea Gallina, et al.
BJU International|October 3, 2007
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogramGeorg C Hutterer, Jean-Jacques Patard, Claudio Jeldres, et al.
BJU International|September 14, 2007
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survivalPatrick J Bastian, Georg C Hutterer, Shahrokh F Shariat, et al.
International Journal of Molecular Sciences|October 17, 2018
MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor PatientsAngelika Terbuch, Jan B Adiprasito, Verena Stiegelbauer, et al.
Frontiers in Oncology|December 16, 2021
Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)Steffen Lebentrau, Gamal Anton Wakileh, Martin Schostak, et al.
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
Cancers|December 23, 2023
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder CancerLukas Scheipner, Hanna Zurl, Julia V Altziebler, et al.
Pageof 9